Lipids

, Volume 34, Supplement 1, pp S19–S22

Dietary fatty acids and coronary heart disease

  • Arne Nordøy
Plenary Lectures

Abstract

The effects of dietary fats have been established in epidemiological and intervention studies and through relationship to risk factors for development of coronary heart disease (CHD). During a period where the impressive effects of hydroxymethylglutaryl-CoA reductase inhibitors on the mortality of CHD dominate the medical journals, it is important to realize the major effects of dietary fatty acids on a series of events included in the multifactorial disorder of CHD.

Abbreviations

CHD

coronary heart disease

MUFA

monounsaturated fatty acid

PUFA

polyunsaturated fatty acid

References

  1. 1.
    Scandinavian Simvastatin Survival Study Group (1994) Randomized Trial of Cholesterol-Lowering in 4444 Patients with Coronary Heart Disease: The Scandinavian Simvastatin Survival Study (4S),Lancet 344, 1863–1869.CrossRefGoogle Scholar
  2. 2.
    Shepherd, J., Cobbe, S.M., Ford, I., Isles, C.G., Lorimer, A.R., MacFarlane, P.W., McKilop, J.H., and Packard, C.C. (1995) Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia,N. Engl. J. Med. 20, 1301–1307.CrossRefGoogle Scholar
  3. 3.
    Sacks, F.M., Pfeiffer, M.D., Moye, L.A., Rouleau, J.L., Rutherford, J.D., Cole, T.G., Brown, L., Warnica, J.W., Arnold, J.M.O., Wun, C.-C., Davis, B.R., and Braunwald, E. (1996) The Effect of Pravastatin on Coronary Events After Myocardial Infarction in Patients with Average Cholesterol Levels,N. Engl. J. Med. 334, 1001–1009.CrossRefGoogle Scholar
  4. 4.
    Simes, R.J., Watson, J., Anderson, N., Hankey, G., Simes, S., and Tonkin, A. (1998) Pravastatin Reduces Total Mortality in Patients with Coronary Heart Disease and Average Cholesterol Levels: Relationship of Baseline Cholesterol and Treatment Effect in the LIPID Trial,J. Am. Coll. Cardiac (Abstr.) 31, 1116–1124.Google Scholar
  5. 5.
    Gould, A.L., Rossouw, J.E., Santanello, N.C., Heyse, J.F., and Furberg, C.D. (1998) Cholesterol Reduction Yields Clinical Benefit,Circulation 97, 946–952.PubMedGoogle Scholar
  6. 6.
    Verschuren, W.M.M., Jacobs, D.R., Bloemberg, B.P.M., Kromhout, D., Menotti, K., Aravanis, Q., Blackburn, H., Buzinar, R., Dontas, A.S., and Froanza, F. (1995) Serum Total Cholesterol and Long-Term Coronary Heart Disease Mortality in Different Cultures,JAMA 274, 131–136.PubMedCrossRefGoogle Scholar
  7. 7.
    Committee on Diet and Health Food and Nutrition Board Commission on Life Sciences National Research Council (1989), inDiet and Health: Implications for Reducing Chronic Disease Risk, pp. 161–168, National Academy Press, Washington, D.C.Google Scholar
  8. 8.
    Strøm, A., and Jensen, R.A. (1952) Mortality from Circulatory Diseases in Norway,Lancet 1, 126–130.Google Scholar
  9. 9.
    Keys, A. (1957) Diet and the Epidemiology of Coronary Heart Disease,JAMA 164, 1912–1919.Google Scholar
  10. 10.
    Dawber, T.R., Moore, F.E., and Makk, G.V. (1957) Coronary Heart Disease in the Framingham Study,Am. J. Pub. Health 47, suppl. April, 4–24.Google Scholar
  11. 11.
    Okuyama, H., Kobayashi, T., and Watawabe, S. (1997) Dietary Fatty Acids—the n-6/n-3 Balance and Chronic Elderly Diseases. Excess Linoleic Acid and Relative n-3 Deficiency Syndrome Seen in Japan,Progr. Lipid Res. 35, 409–457.CrossRefGoogle Scholar
  12. 12.
    Dyerberg, J., Bang, H.O., Stoffersen, E., Moncada, S., and Vane, J.R. (1978) Eicosapentaenoic Acid and Prevention of Thrombosis and Atherosclerosis,Lancet 2, 117–119.PubMedCrossRefGoogle Scholar
  13. 13.
    Nestel, P.J. (1995) Controlling Coronary Risk Through Nutrition,Am. J. Cardiol. 11, suppl. 6, 9–14.Google Scholar
  14. 14.
    Hu, F.B., Stampfer, M.J., Manson, J.E., Rinn, E., Colditz, G.A., Rosner, B.A., Hennekens, C.H., and Willett, W.C. (1997) Dietary Fat Intake and the Risk of Coronary Heart Disease in Women,N. Engl. J. Med. 337, 1491–1499.PubMedCrossRefGoogle Scholar
  15. 15.
    Esrey, K.L., Joseph, L., and Grover, S.A. (1996) Relationship Between Dietary Intake and Coronary Heart Disease Mortality: Lipid Research Clinics Prevalence Follow-Up Study,J. Clin. Epidemiol. 49, 211–216.PubMedCrossRefGoogle Scholar
  16. 16.
    Nordøy, A. (1996) Fish Consumption and Cardiovascular Disease: A Reappraisal,Nutr. Metab. Cardiovasc. Dis. 6, 103–109.Google Scholar
  17. 17.
    Billman, G.E., Hallag, H., and Leaf, A. (1994) Prevention of Ischemia-Induced Ventricular Fibrillation by θ-3 Fatty Acids,Proc. Natl. Acad. Sci. USA, 91, 4427–4430.PubMedCrossRefGoogle Scholar
  18. 18.
    McLennan, P.L., Bridle, T.M., Abeywardena, M.Y., and Charnock, J.S. (1992) Dietary Lipid Modulation of Ventricular Fibrillation Threshold in the Marmoset Monkey,Am. Heart J. 123, 1555–1561.PubMedCrossRefGoogle Scholar
  19. 19.
    Sisovick, D.S., Raghuthan, T.E., King, I., Weinman, S., Wicklund, K.G., Albright, J., Boubjerg, M., Arbogast, P., Smith, H., Kushi, L.H., Cobb, L.A., Copass, M.K., Psaty, B.M., Lemaitre, R., Retzlaff, B., Childs, M., and Knopp, R.H. (1995) Dietary Intake and Cell Membrane Levels of Long-Chain n-3 Polyunsaturated Fatty Acids and the Risk of Primary Cardiac Arrest,JAMA 274, 1363–1367.CrossRefGoogle Scholar
  20. 20.
    Burr, M.L., Gilbert, J.F., Holliday, R.M., Elwood, P.C., Fehily, A.M., Rogers, S., Sweetnam, P.M., and Deadman, N.M. (1989) Effects of Changes in Fat, Fish and Fibre Intakes on Death and Myocardial Reinfarction: Diet and Reinfarction Trial (DART),Lancet 2, 757–761.PubMedCrossRefGoogle Scholar
  21. 21.
    deLorgeril, M., Renaud, S., Mamelle, N., Salen, P., Martin, J.L., Monjaud, I., Guidollet, J., Touboul, P., and Delaje, J. (1994) Mediterranean Alpha-Linolenic Acid-Rich Diet in Secondary Prevention of Coronary Heart Disease,Lancet 143, 1454–1459.CrossRefGoogle Scholar
  22. 22.
    Multiple Risk Factor Intervention Trial. Research Group (1982) Multiple Risk Factor Intervention Trial,JAMA 248, 1465–1477.CrossRefGoogle Scholar
  23. 23.
    Hjermann, I., Byre, K.V., Holme, I., and Leren, P. (1981) Effect of Diet and Smoking Intervention on the Incidence of Coronary Heart Disease. Report from the Oslo Study Group of a Randomized Trial in Healthy Men,Lancet 2, 1303–1310.PubMedCrossRefGoogle Scholar
  24. 24.
    Hjermann, I., Holme, I., and Leren, P. (1986) Oslo Study Diet and Anti-Smoking Trial. Results After 102 Months,Am. J. Med. 80, suppl. 2A, 7–11.PubMedCrossRefGoogle Scholar
  25. 25.
    Contacos, C., Barter, P.J., and Sullivan, D.R. (1993) Effect of Pravastatin and θ-3 Fatty Acids on Plasma Lipids and Lipoproteins in Patients with Combined Hyperlipemia,Arterioscler. Thromb. 13, 1755–1762.PubMedGoogle Scholar
  26. 26.
    Nordøy, A., Bønaa, K.H., Nilsen, H., Berg, R.K., Hansen, J.B., and Ingebretsen, O.C. (1998) Effects of Simvastatin and Omega-3 Fatty Acids on Plasma Lipoproteins and Lipid Peroxidation in Patients with Combined Hyperlipemia,J. Intern. Med. 242, 163–170.CrossRefGoogle Scholar

Copyright information

© AOCS Press 1999

Authors and Affiliations

  • Arne Nordøy
    • 1
  1. 1.Department of Medicine, Institute of Clinical MedicineUniversity of TromsøTromsøNorway

Personalised recommendations